Medical News

RSS

AAN awards Cedars-Sinai researcher 2010 Sheila Essey Award for ALS research

The American Academy of Neurology (AAN) is awarding the 2010 Sheila Essey Award-An Award for ALS Research to Clive Svendsen, PhD, with the Cedars-Sinai Regenerative Medicine Institute in Los Angeles, CA. Svendsen will receive the award during the AAN's 62nd Annual Meeting in Toronto, held April 10 through April 17, 2010.

31 Mar 2010

Study finds rapid epidemiological shift in HAV infection in Korea

In Korea, there has been a rapid epidemiological shift in hepatitis A virus infection as a result of rapid economic development. The adult cases of acute hepatitis A have increased rapidly during the past 10 years due to the emergence of susceptible adults in Korea.

31 Mar 2010

High radon levels in residential buildings can cause lung cancer

About 1900 deaths from lung cancer per year in Germany are due to radon within residential buildings. This was the conclusion reached in the current edition of Deutsches -rzteblatt International by Klaus Schmid of the University of Erlangen-Nuremberg and his coauthors (Dtsch Arztebl Int 2010; 107(11): 181-6).

31 Mar 2010

New finding reveals how brain constructs morality

MIT neuroscientists have shown they can influence people's moral judgments by disrupting a specific brain region - a finding that helps reveal how the brain constructs morality.

31 Mar 2010

Sanofi Pasteur accelerates deployment of Intercim's Pertinence Suite MOM software solution

Intercim, announces that Sanofi Pasteur, the vaccines division of the Sanofi-aventis Group, is accelerating the use of Pertinence Suite, Manufacturing Operations Management (MOM) software solution, within the European and North American sites of the worldwide leader of vaccines.

31 Mar 2010

Vantage Communications becomes agency of record for ImThera Medical

Vantage Communications, an award-winning global PR firm, today announced that it is the agency of record for ImThera Medical, Inc. Within a few months, Vantage Communications successfully promoted ImThera and its medical device technology with original coverage garnered in top-tier publications such as Neurotech Insights, ENToday, The Gray Sheet, Sleep Review, Respiratory & Sleep Management, Respiratory Therapy, Medical Device Daily, and medGadget.

31 Mar 2010

Guided Therapeutics' LightTouch Cervical Scanner demonstrates increased detection of disease over Pap tests

The Guided Therapeutics, Inc. LightTouch™ Cervical Scanner increased detection of significant disease over Pap tests in women seen in a busy private practice setting, according to results of a U.S. Food and Drug Administration pivotal clinical trial presented at the American Society for Colposcopy and Cervical Pathology biennial meeting.

31 Mar 2010

2010 John Dystel Prize for Multiple Sclerosis Research awarded to Yale University researcher

The American Academy of Neurology is awarding the 2010 John Dystel Prize for Multiple Sclerosis Research to David A. Hafler, MD, with Yale University. Hafler will receive the award during the AAN's 62nd Annual Meeting in Toronto, held April 10 through April 17, 2010.

31 Mar 2010

March of Dimes declares 2010 Colorado funding for mom and baby health programs

The March of Dimes today announced its 2010 Colorado funding for mom and baby health programs. In total, the organization will invest $1,959,227 in research, services, education and advocacy programs.

31 Mar 2010

Prevalence of head and neck cancer linked to human papillomavirus

Rates of oropharangeal cancer have increased by around 50 per cent in the last 20 years, according to a report in the British Medical Journal.

31 Mar 2010

Donors will gather at U.N. Wednesday to discuss Haiti relief, recovery

At a donors conference beginning on Wednesday at the U.N. in New York, Haitian President Rene Preval will lay out a $3.8 billion plan "to begin radically reshaping his country's post-earthquake economy and infrastructure," the Washington Post reports.

31 Mar 2010

New anti-inflammatory drug shows promise for treating inflammatory disorders

Aspirin, ibuprofen and other non-steroidal anti-inflammatory drugs (NSAIDs) remain the most common treatment to relieve symptoms of arthritis and other inflammatory disorders. But despite their widespread use (around 2.5 million Canadians have osteoarthritis) these medications are also known to cause severe, sometimes life-threatening adverse effects within the body, particularly in the gastrointestinal tract

31 Mar 2010

Mixed poll numbers for Obama, Dems as health reform is signed into law

A USA Today/Gallup Poll has found that almost two out of three of Americans say the health care reform law is too costly and expands the government's role in health care too much, USA Today reports. "Those surveyed are inclined to fear that the massive legislation will increase their costs and hurt the quality of health care their families receive, although they are more positive about its impact on the nation's health care system overall."

31 Mar 2010

WOCN Society launches campaign to raise awareness about benefits of specialized care

Patients and families who are dealing with conditions such as non-healing wounds, bedsores, bladder and bowel incontinence and ostomy-related issues contend with physical symptoms, as well as social and emotional side effects. The impact on patients and families can exact an enormous toll. The Wound Ostomy & Continence Nurses Society is launching a campaign to raise awareness about the benefits of specialized care.

31 Mar 2010

AARP Idaho unveils list of winners and losers of 2010 legislative session

With the 2010 Idaho legislative session drawing to a close, the dust has settled on several key pieces of legislation that deliver good news and bad news for people across the state. Today, AARP Idaho unveiled its list of "2010 Legislative Session Winners and Losers," highlighting bills that either help or hurt Idahoans.

31 Mar 2010

Nymox Pharmaceutical's NX-1207 human clinical trials for HCC demonstrate favorable safety data

Nymox Pharmaceutical Corporation outlined today the Company's development program for the Company's lead drug candidate, NX-1207, currently in Phase 3 trials in the U.S. for the treatment of benign prostatic hyperplasia (BPH). The drug has been successful in a series of blinded controlled multi-center U.S. clinical trials where it has been found to produce improvements that are about double that reported for currently approved BPH drugs.

31 Mar 2010

Evergreen Hospital Medical Center plans open new ED in Redmond

Evergreen Hospital Medical Center announced plans today to open a Redmond Emergency Department. Hospital leaders and physicians say the new ED will give area residents improved access to round-the-clock health care.

31 Mar 2010

Fairbanks Institute and BioServe to co-market next generation biorepository, INbank

The Fairbanks Institute for Healthy Communities, the Indianapolis not-for-profit organization working to improve community health, and BioServe, a global provider of biomaterial and genetic research services, today announced that they will co-market INbank™, a next generation biorepository that was recently launched by The Fairbanks Institute.

31 Mar 2010

CDC, Surgeon General report on increased number of H1N1 cases in southeast U.S.

Although H1N1 (swine flu) "has waned across much of the United States, the southeast is reporting an increase in cases of the H1N1 virus, U.S. health officials said on Monday," Reuters reports.

31 Mar 2010

Health Care REIT prices 6.125% senior unsecured notes due 2020 at 99.297% of face amount

Health Care REIT, Inc. today announced that it has priced an offering of $300 million of 6.125% senior unsecured notes due April 15, 2020. The notes were priced at 99.297% of their face amount to yield 6.22%. Subject to customary closing conditions, the offering is expected to close on April 7, 2010.

31 Mar 2010